Fu­ji­film makes $200M man­u­fac­tur­ing in­vest­ment while No­var­tis pours $80M+ in­to Chi­na fa­cil­i­ty

Fu­ji­film Cor­po­ra­tion is in­vest­ing $200 mil­lion in­to two of its sub­sidiaries to ex­pand its cell ther­a­py con­tract de­vel­op­ment and man­u­fac­tur­ing, the com­pa­ny an­nounced Mon­day.

The in­vest­ment will go, in part, to­ward its new head­quar­ters for Fu­ji­film Cel­lu­lar Dy­nam­ics, which de­vel­ops and man­u­fac­tures hu­man-in­duced pluripo­tent stem cells and iP­SC-de­rived cells. The head­quar­ters will be 175,000 square feet in Madi­son, WI, and will dou­ble its man­u­fac­tur­ing ca­pac­i­ty for iP­SC-de­rived cell ther­a­pies. It’ll be op­er­a­tional in the spring of 2026.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER